Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors

November 29, 2017 Leave a comment 3,333 Views

Envisagenics, Inc., a biotechnology company that applies Artificial Intelligence to the genetic sequence of patients to discover new therapies, announced today that is has raised $2.35M in its seed round. The investors include Third Kind Venture Capital (3KVC), Cosine, LLC ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Cosine

Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors

Single-cell RNA and protein expression in relation to cell cycle progression

Evaluating capture sequence performance for single-cell CRISPR activation experiments

Seven Bridges Selected by Pfizer to Support Data Management Solution for Single-Cell RNA Sequencing Data

Single-cell mapper (scMappR) – using scRNA-seq to infer the cell-type specificities of differentially expressed genes

Featured RNA-Seq Job – Staff Bioinformatics Scientist, RNA-Seq

Introduction to NGS – RNA-Seq Data Analysis – DNA Variant Calling

Yale neurologists use RNA sequencing to identify consistent neuroinflammatory response in ICH patients